Evidence map›Paper›PMID 41529728›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2026

Amelogenin proteolysis orchestrates functional amyloid pathways in enamel development.

Emerson Tavares de Sousa, Larry Ackerman, Johan Svensson Bonde, Stefan Habelitz, Yushi Bai

Abstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emerson Tavares de SousaDepartment of Preventive and Restorative Dental Sciences, School of Dentistry, University of California, San Francisco, USA.
Larry AckermanDepartment of Preventive and Restorative Dental Sciences, School of Dentistry, University of California, San Francisco, USA; Department of Biochemistry and Biophysics, School of Medicine, University of California, San Francisco, USA.
Johan Svensson BondeDivision of Pure and Applied Biochemistry, Department of Chemistry, Lund University, Sweden.
Stefan HabelitzDepartment of Preventive and Restorative Dental Sciences, School of Dentistry, University of California, San Francisco, USA. Electronic address: Stefan.habelitz@ucsf.edu.
Yushi BaiThe First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, Hainan 571199, China. Electronic address: Yushi.bai@muhn.edu.cn.

Funding

Amelogenin Nanoribbons In Enamel Development And EngineeringR01DE031946 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Stefan Friedrich Habelitz · 2022 to 2026
$3.4M
National Institute of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) RO1-DE025709National Natural Science Foundation of China 32301042NIDCR NIH HHS R01 DE031946
6 · The paper itself

Abstract

Amelogenin, the most abundant protein in developing enamel, self-assembles into supramolecular structures that serve as templates for apatite growth. Recent studies revealed that amelogenin nanoribbons exhibit hallmark features of functional amyloids, yet the molecular mechanisms governing their formation remain incompletely understood. Here, we combine atomic force microscopy, transmission electron microscopy, and spectroscopic analyses to define the assembly pathways of full-length amelogenin (rH174) alongside its major proteolytic products generated by metalloproteinase-20 (MMP20). We demonstrate that both rH174 and the C-terminally truncated rH146 follow a nucleated conformational conversion mechanism, progressing from spherical oligomers through proto-ribbons to ordered β-sheet-rich nanoribbons. rH174 assembly progresses slowly, displaying an extended lag phase and delayed maturation, whereas rH146 nucleates rapidly, completing these stages within a shorter timeframe. Cross-seeding of rH146 into rH174 monomers (1:10) eliminates the delay in rH174 assembly, rapidly driving the system into elongation and leading to an earlier stabilization of the assembly system. C-terminus-driven interactions in rH174 trigger secondary nucleation that evolves into bundled nanoribbons resembling enamel organization, a process largely absent in rH146. Cross-seeding, therefore, exemplifies the in vivo mechanism whereby nascent amelogenin is immediately added to existing nanoribbon scaffolds, a cooperative strategy that generates a heterogeneous matrix, coupling the ability of rapid nucleation and spatial organization. Unexpectedly, the MMP20 cleavage product - TRAP, which comprises the cross-beta assembly domain, does not form nanoribbons and diverts from the assembly pathway full-length amelogenin takes when hydrolyzed at the C-terminal. Hence, a MMP20-driven mechanism exists that could contribute to an enamel matrix that acts as a spacer and prevents early crystal fusion during the secretory stage of amelogenesis. These findings offer insights into a proteolysis-triggered assembly pathway that may reconcile long-standing supramolecular models of amelogenin and establish amelogenin as a vertebrate example of a functional amyloid that can be tuned to enable ordered enamel biomineralization.

Indexed as

AmelogenesisAmelogeninAmyloidDental EnamelMatrix Metalloproteinase 20AnimalsMiceMicroscopy, Atomic ForceProteolysisAmelogeninAmyloidMatrix Metalloproteinase 20Mmp20 protein, mouseAmelogenesisEnamel MatrixProtein-guided mineralizationProtein-protein interactionsß-sheet nanostructures

Identifiers

PMID41529728
PMCPMC12983448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.